C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 16/18 (2006.01) A61K 39/395 (2006.01) A61P 25/28 (2006.01) C07K 16/46 (2006.01) C12N 5/16 (2006.01) C12N 15/09 (2006.01) C12N 15/13 (2006.01) C12P 21/08 (2006.01) G01N 33/53 (2006.01) G01N 33/564 (2006.01)
Patent
CA 2671217
The subject invention relates to monoclonal antibodies that may be used in the treatment and diagnosis of Alzheimer's Disease. In particular, the present invention relates to monoclonal antibodies referred to as 10F4 and 3C5 and to other monoclonal antibodies (e.g., murine, human or humanized) having similar properties thereto.
Cette invention concerne des anticorps monoclonaux susceptibles d'être utilisés dans le traitement et le diagnostic de la maladie d'Alzheimer. L'invention concerne en particulier des anticorps monoclonaux désignés 10F4 et 3C5 et d'autres anticorps monoclonaux (par exemple murins, humains ou humanisés) ayant des propriétés semblables aux dits anticorps.
Barghorn Stefan
Ebert Ulrich
Hillen Heinz
Keller Patrick
Labkovsky Boris
Abbott Gmbh & Co. Kg
Abbott Laboratories
Barghorn Stefan
Ebert Ulrich
Hillen Heinz
LandOfFree
New a.beta. conformer selective anti-a.beta. globulomer... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with New a.beta. conformer selective anti-a.beta. globulomer..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and New a.beta. conformer selective anti-a.beta. globulomer... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1456810